IMR Press / FBL / Volume 24 / Issue 8 / DOI: 10.2741/4789

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

The dawn of pirna research in various neuronal disorders
Show Less
1 Department of Applied Biology Kyoto Institute of Technology, Kyoto 606-8585, Japan
2 Department of Research for Parkinson’s Disease, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan
3 Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan
*Correspondence: (Keiko Tsuji Wakisaka)
Front. Biosci. (Landmark Ed) 2019, 24(8), 1440–1451;
Published: 1 June 2019
(This article belongs to the Special Issue Cutting edge of insect biomedical science)

Small non-coding PIWI-interacting RNAs (piRNAs) silence the expression of transposable elements integrated in a wide range of eukaryotic genomes in germline cells. Additionally, piRNAs regulate chromatin modifications, such as trimethylation of histone H3 lysine 9 (H3K9me3) or DNA methylation. In the past decade, the roles of piRNAs have been characterized in somatic cells, including post-mitotic neurons. More recently, piRNAs have been shown to play important roles in brain functions and various neuronal diseases, including neurodegenerative disorders. In this review, we introduce recent findings showing the potential involvement of piRNAs in the etiology of different neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Alzheimer’s disease (AD) and Parkinson’s disease (PD). These pioneering studies on disease-associated small RNAs will contribute to improving our understanding of the pathogenesis of these neurodegenerative diseases and the development of novel therapeutic strategies.

Neuronal Disease
Figure 1.
Back to top